Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Patients with moderate to severe strokes (NIHSS score >10) undergoing urgent carotid interventions within 48 hours have worse functional outcomes.

Mihindu E, Mohammed A, Smith T, Brinster C, Sternbergh WC 3rd, Bazan HA.

J Vasc Surg. 2019 May;69(5):1471-1481. doi: 10.1016/j.jvs.2018.07.079. Epub 2019 Jan 8.

PMID:
30635157
2.

Fenestrated endovascular aortic repair and clinical trial devices for complex abdominal aortic aneurysms.

Brinster CJ, Milner R.

J Cardiovasc Surg (Torino). 2018 Jun;59(3):342-359. doi: 10.23736/S0021-9509.18.10460-5. Epub 2018 Mar 19. Review.

PMID:
29557587
3.

Sub-clonal analysis of the murine C1498 acute myeloid leukaemia cell line reveals genomic and immunogenic diversity.

Driss V, Leprêtre F, Briche I, Mopin A, Villenet C, Figeac M, Quesnel B, Brinster C.

Immunol Lett. 2017 Dec;192:27-34. doi: 10.1016/j.imlet.2017.10.004. Epub 2017 Oct 10.

PMID:
29030252
4.

Complications after endovascular treatment of hepatic artery stenosis after liver transplantation.

Goldsmith LE, Wiebke K, Seal J, Brinster C, Smith TA, Bazan HA, Sternbergh WC 3rd.

J Vasc Surg. 2017 Nov;66(5):1488-1496. doi: 10.1016/j.jvs.2017.04.062. Epub 2017 Jul 8.

5.

A Detailed Protocol for Characterizing the Murine C1498 Cell Line and its Associated Leukemia Mouse Model.

Mopin A, Driss V, Brinster C.

J Vis Exp. 2016 Oct 14;(116). doi: 10.3791/54270.

6.

Retrograde Target Vessel Catheterization as a Salvage Procedure in Fenestrated/Branched Endografting.

Oikonomou K, Katsargyris A, Brinster CJ, Renner H, Ritter W, Verhoeven EL.

J Endovasc Ther. 2015 Aug;22(4):603-9. doi: 10.1177/1526602815592205. Epub 2015 Jun 19.

PMID:
26092541
7.

Monocyte chemoattractant protein 1 (MCP-1/CCL2) contributes to thymus atrophy in acute myeloid leukemia.

Driss V, Quesnel B, Brinster C.

Eur J Immunol. 2015 Feb;45(2):396-406. doi: 10.1002/eji.201444736. Epub 2014 Dec 4.

8.

Augmented mitral valve leaflet area decreases leaflet stress: a finite element simulation.

Xu C, Jassar AS, Nathan DP, Eperjesi TJ, Brinster CJ, Levack MM, Vergnat M, Gorman RC, Gorman JH 3rd, Jackson BM.

Ann Thorac Surg. 2012 Apr;93(4):1141-5. doi: 10.1016/j.athoracsur.2012.01.069. Epub 2012 Mar 6.

9.

A novel two-stage surgical approach for the treatment of symptomatic supra-aortic artery aneurysms.

Ullery BW, Foley PJ, Brinster CJ, Pochettino A, Fairman RM.

Vascular. 2012 Aug;20(4):236-40. doi: 10.1258/vasc.2011.cr0287. Epub 2011 Oct 26.

PMID:
22030356
10.

Predictors of decreased short- and long-term survival following open abdominal aortic aneurysm repair.

Nathan DP, Brinster CJ, Jackson BM, Wang GJ, Carpenter JP, Fairman RM, Woo EY.

J Vasc Surg. 2011 Nov;54(5):1237-43. doi: 10.1016/j.jvs.2011.05.028. Epub 2011 Aug 15.

11.

Late open conversion and explantation of abdominal aortic stent grafts.

Brinster CJ, Fairman RM, Woo EY, Wang GJ, Carpenter JP, Jackson BM.

J Vasc Surg. 2011 Jul;54(1):42-6. doi: 10.1016/j.jvs.2010.12.042. Epub 2011 Feb 18.

12.

Quantitative mitral valve modeling using real-time three-dimensional echocardiography: technique and repeatability.

Jassar AS, Brinster CJ, Vergnat M, Robb JD, Eperjesi TJ, Pouch AM, Cheung AT, Weiss SJ, Acker MA, Gorman JH 3rd, Gorman RC, Jackson BM.

Ann Thorac Surg. 2011 Jan;91(1):165-71. doi: 10.1016/j.athoracsur.2010.10.034.

13.

Predictors of early and late mortality following open extent IV thoracoabdominal aortic aneurysm repair in a large contemporary single-center experience.

Nathan DP, Brinster CJ, Woo EY, Carpenter JP, Fairman RM, Jackson BM.

J Vasc Surg. 2011 Feb;53(2):299-306. doi: 10.1016/j.jvs.2010.08.085. Epub 2010 Nov 20.

14.

A novel approach to in vivo mitral valve stress analysis.

Xu C, Brinster CJ, Jassar AS, Vergnat M, Eperjesi TJ, Gorman RC, Gorman JH 3rd, Jackson BM.

Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1790-4. doi: 10.1152/ajpheart.00370.2010. Epub 2010 Oct 15.

15.

Endovascular repair of extent I thoracoabdominal aneurysms with landing zone extension into the aortic arch and mesenteric portion of the abdominal aorta.

Brinster CJ, Szeto WY, Bavaria JE, Woo EY, Fairman RM, Jackson BM.

J Vasc Surg. 2010 Aug;52(2):460-3. doi: 10.1016/j.jvs.2010.03.010. Epub 2010 Jun 11.

16.

Isolation of dendritic cells.

Inaba K, Swiggard WJ, Steinman RM, Romani N, Schuler G, Brinster C.

Curr Protoc Immunol. 2009 Aug;Chapter 3:Unit 3.7. doi: 10.1002/0471142735.im0307s86.

PMID:
19653207
17.

Modulation of the TCR stimulation strength can render human activated CD4+ T cells suppressive.

Noël G, Brinster C, Semana G, Bruniquel D.

Int Immunol. 2009 Sep;21(9):1025-36. doi: 10.1093/intimm/dxp068. Epub 2009 Jul 22.

PMID:
19625380
18.

Availability of autoantigenic epitopes controls phenotype, severity, and penetrance in TCR Tg autoimmune gastritis.

Levin D, DiPaolo RJ, Brinster C, Revilleza MJ, Boyd LF, Teyton L, Natarajan K, Mage MG, Shevach EM, Margulies DH.

Eur J Immunol. 2008 Dec;38(12):3339-53. doi: 10.1002/eji.200838584.

19.

Patients suffering from acute graft-versus-host disease after bone-marrow transplantation have functional CD4+CD25hiFoxp3+ regulatory T cells.

Noël G, Bruniquel D, Birebent B, DeGuibert S, Grosset JM, Bernard M, Dauriac C, Chevallier P, Lamy-de-la-Chapelle T, Semana G, Brinster C.

Clin Immunol. 2008 Nov;129(2):241-8. doi: 10.1016/j.clim.2008.07.019. Epub 2008 Aug 29.

PMID:
18760679
20.

Regulatory CD4+CD25hi T cells conserve their function and phenotype after granulocyte colony-stimulating factor treatment in human hematopoietic stem cell transplantation.

Noël G, Bruniquel D, DeGuibert S, Birebent B, Grosset JM, Bernard M, Dauriac C, Lamy-de-la-Chapelle T, Semana G, Brinster C.

Hum Immunol. 2008 Jun;69(6):329-37. doi: 10.1016/j.humimm.2008.04.008. Epub 2008 May 15.

PMID:
18571003
21.

Costimulatory effects of IL-1 on the expansion/differentiation of CD4+CD25+Foxp3+ and CD4+CD25+Foxp3- T cells.

Brinster C, Shevach EM.

J Leukoc Biol. 2008 Aug;84(2):480-7. doi: 10.1189/jlb.0208085. Epub 2008 May 13.

22.

Autoantigen-specific TGFbeta-induced Foxp3+ regulatory T cells prevent autoimmunity by inhibiting dendritic cells from activating autoreactive T cells.

DiPaolo RJ, Brinster C, Davidson TS, Andersson J, Glass D, Shevach EM.

J Immunol. 2007 Oct 1;179(7):4685-93.

23.

Outcomes after 151 extended transcervical thymectomies for myasthenia gravis.

Shrager JB, Nathan D, Brinster CJ, Yousuf O, Spence A, Chen Z, Kaiser LR.

Ann Thorac Surg. 2006 Nov;82(5):1863-9.

PMID:
17062262
25.

Evolving options in the management of esophageal perforation.

Brinster CJ, Singhal S, Lee L, Marshall MB, Kaiser LR, Kucharczuk JC.

Ann Thorac Surg. 2004 Apr;77(4):1475-83. Review.

PMID:
15063302
26.

Current management of esophageal leiomyoma.

Lee LS, Singhal S, Brinster CJ, Marshall B, Kochman ML, Kaiser LR, Kucharczuk JC.

J Am Coll Surg. 2004 Jan;198(1):136-46. Review. No abstract available.

PMID:
14698321
27.

Control of heterologous hepatitis C virus infection in chimpanzees is associated with the quality of vaccine-induced peripheral T-helper immune response.

Rollier C, Depla E, Drexhage JA, Verschoor EJ, Verstrepen BE, Fatmi A, Brinster C, Fournillier A, Whelan JA, Whelan M, Jacobs D, Maertens G, Inchauspé G, Heeney JL.

J Virol. 2004 Jan;78(1):187-96.

28.

Restoration of fertility by germ cell transplantation requires effective recipient preparation.

Brinster CJ, Ryu BY, Avarbock MR, Karagenc L, Brinster RL, Orwig KE.

Biol Reprod. 2003 Aug;69(2):412-20. Epub 2003 Apr 2.

PMID:
12672656
29.

Maintenance of mouse male germ line stem cells in vitro.

Nagano M, Ryu BY, Brinster CJ, Avarbock MR, Brinster RL.

Biol Reprod. 2003 Jun;68(6):2207-14. Epub 2003 Jan 22.

PMID:
12606373
30.

Transcervical thymectomy for myasthenia gravis achieves results comparable to thymectomy by sternotomy.

Shrager JB, Deeb ME, Mick R, Brinster CJ, Childers HE, Marshall MB, Kucharczuk JC, Galetta SL, Bird SJ, Kaiser LR.

Ann Thorac Surg. 2002 Aug;74(2):320-6; discussion 326-7.

PMID:
12173807
31.

Hepatitis C virus non-structural protein 3-specific cellular immune responses following single or combined immunization with DNA or recombinant Semliki Forest virus particles.

Brinster C, Chen M, Boucreux D, Paranhos-Baccala G, Liljeström P, Lemmonier F, Inchauspé G.

J Gen Virol. 2002 Feb;83(Pt 2):369-381. doi: 10.1099/0022-1317-83-2-369.

PMID:
11807230
32.

Different hepatitis C virus nonstructural protein 3 (Ns3)-DNA-expressing vaccines induce in HLA-A2.1 transgenic mice stable cytotoxic T lymphocytes that target one major epitope.

Brinster C, Muguet S, Lone YC, Boucreux D, Renard N, Fournillier A, Lemonnier F, Inchauspé G.

Hepatology. 2001 Dec;34(6):1206-17.

PMID:
11732011
33.

Transgenic mice produced by retroviral transduction of male germ-line stem cells.

Nagano M, Brinster CJ, Orwig KE, Ryu BY, Avarbock MR, Brinster RL.

Proc Natl Acad Sci U S A. 2001 Nov 6;98(23):13090-5. Epub 2001 Oct 23.

34.

DNA vaccines for hepatitis C virus.

Brinster C, Inchauspé G.

Intervirology. 2001;44(2-3):143-53. Review.

PMID:
11509875
35.

Expanded indications for transcervical thymectomy in the management of anterior mediastinal masses.

Deeb ME, Brinster CJ, Kucharzuk J, Shrager JB, Kaiser LR.

Ann Thorac Surg. 2001 Jul;72(1):208-11.

PMID:
11465181
36.

Use of conventional or replicating nucleic acid-based vaccines and recombinant Semliki forest virus-derived particles for the induction of immune responses against hepatitis C virus core and E2 antigens.

Vidalin O, Fournillier A, Renard N, Chen M, Depla E, Boucreux D, Brinster C, Baumert T, Nakano I, Fukuda Y, Liljeström P, Trépo C, Inchauspé G.

Virology. 2000 Oct 25;276(2):259-70.

37.

Culture of mouse spermatogonial stem cells.

Nagano M, Avarbock MR, Leonida EB, Brinster CJ, Brinster RL.

Tissue Cell. 1998 Aug;30(4):389-97.

38.

Reconstitution of spermatogenesis from frozen spermatogonial stem cells.

Avarbock MR, Brinster CJ, Brinster RL.

Nat Med. 1996 Jun;2(6):693-6.

Supplemental Content

Loading ...
Support Center